Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA’s Rasonque review documents pressure RevMed
FDA review documents released Thursday fueled investor anxiety over Rasonque’s performance in patients with KRAS G12D tumors.
Angus Liu
Oct 9, 2026 11:25am
Quince, now IRuyla, debuts new name, focus and leadership
Oct 9, 2026 11:05am
For biopharma manufacturing at speed and scale, the future is flexible
Brought to you by
Resilience
Teva bags long-sought reformulated olanzapine schizophrenia nod
Oct 9, 2026 9:56am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Novartis, Shionogi, ArriVent—Fierce Pharma Asia
Oct 9, 2026 8:30am
